N4 Pharma Company Description

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.

It develops Nuvec, which offers silica nanoparticles with irregular surface structure and polyethyleneimine that traps and protects nucleic acid; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene for the treatment of glaucoma.

The company was incorporated in 1979 and is based in London, the United Kingdom.

N4 Pharma Plc

Country	United Kingdom
Founded	1979
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	5
CEO	Nigel Theobald

Contact Details

Address: 60 Gracechurch Street London, EC3V 0HR United Kingdom
Website	n4pharma.com

Stock Details

Ticker Symbol	N4P
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BYW8QM32
SIC Code	2835

Key Executives

Name	Position
Nigel Theobald	Chief Executive Officer